Mission Therapeutics
Latest round
- Series D
Last raised
- Mar 2024
Total raised
- $134M
Investors
- 14
About Mission Therapeutics
Founded in 2011 by co-founders Niall Martin, Steve Jackson, and Xavier Jacq and based in Cambridge, UK, Mission Therapeutics Ltd. develops deubiquitylating enzyme drugs for the treatment of life-threatening diseases like neurodegenerative disease, kidney disease, fibrosis, and rare mitochondrial diseases. In March 2024, Mission Therapeutics Ltd. Mission Therapeutics' product portfolio includes small-molecule inhibitors of specific DUBs. The company has developed a comprehensive library of more than 17,000 DUB-specific compounds, from which several lead candidates have emerged. Among these, MTX652 and MTX325, both targeting the DUB USP30, MTX652 has advanced into clinical trials, while MTX325 is in pre-clinical development. These specific mitochondrial-associated DUBs with inhibitors are designed to treat a range of diseases, including heart failure, neurodegenerative diseases, including parkinson’s disease, duchenne muscular dystrophy (DMD), renal diseases such as acute kidney injury (AKI) and chronic kidney disease (CKD), as well as other indications such as idiopathic pulmonary fibrosis (IPF), and rare genetic mitochondrial diseases.
Who invested in Mission Therapeutics
14 investors across 6 rounds
See all investors in Mission Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Mission Therapeutics
Who invested in Mission Therapeutics?
Mission Therapeutics has 14 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mission Therapeutics raised?
Mission Therapeutics has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Mission Therapeutics last raise money?
Mission Therapeutics's most recent round on record is a Series D, in Mar 2024.
What does Mission Therapeutics do?
Founded in 2011 by co-founders Niall Martin, Steve Jackson, and Xavier Jacq and based in Cambridge, UK, Mission Therapeutics Ltd.
Where is Mission Therapeutics headquartered?
Mission Therapeutics is headquartered in Cambridge, UK.
Which VCs invest in companies like Mission Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Mission Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Mission Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.